p38 mitogen-activated protein kinase and liver X receptor-α mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cells

Molecular Medicine

Volumn 18, Issue 1, 2012, Pages 10-18

  Yan, Kunfeng ^a   Deng, Xiong ^b   Zhai, Xuguang ^a   Zhou, Mingming ^a   Jia, Xin ^a   Luo, Lin ^a   Niu, Minghui ^a   Zhu, Huixia ^a   Qiang, Hui ^a   Zhou, Yajun ^a  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA1(I) COLLAGEN; COLLAGEN; LEPTIN; LIVER X RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE P38; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; STELLATE CELL;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; HEPATIC STELLATE CELLS; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; ORPHAN NUCLEAR RECEPTORS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RATS; REAL-TIME POLYMERASE CHAIN REACTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; SYNAPTOPHYSIN;

EID: 84863012195     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2011.00243     Document Type: Article

References (39)

1. Zhang Y, et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425-432.
2. William WN Jr, Ceddia RB, Curi R. (2002) Leptin controls the fate of fatty acids in isolated rat white adipocytes. J. Endocrinol. 175:735-744.
3. Zhou YT, Wang ZW, Higa M, Newgard CB, Unger RH. (1999) Reversing adipocyte differentiation: implications for treatment of obesity. Proc. Natl. Acad. Sci. U. S. A. 96:2391-2395.
4. García-Suárez C, et al. (2004) Plasma leptin levels in patients with primary biliary cirrhosis and their relationship with degree of fibrosis. Gas-troenterol. Hepatol. 27:47-50.
5. Henriksen JH, Holst JJ, Møller S, Brinch K, Bendtsen F. (1999) Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal. Hepatology. 29:1818-24.
6. Aleffi S, et al. (2005) Upregulation of proinflam-matory and proangiogenic cytokines by leptin in human hepatic stellate cells. Hepatology. 42:1339-1348.
7. Cao Q, Mak KM, Lieber CS. (2006) Leptin enhances alpha1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways. J. Cell. Biochem. 97:188-197.
8. Saxena NK, Ikeda K, Rockey DC, Friedman SL, Anania FA. (2002) Leptin in hepatic fibrosis: evidence for increased collagen production in stellate cells and lean littermates of ob/ob mice. He-patology. 35:762-771.
9. Tang Y, Chen A. (2010) Curcumin protects hepatic stellate cells against leptin-induced activation in vitro by accumulating intracellular lipids. Endocrinology. 151:4168-4177.
10. Zhou Y, et al. (2010) Leptin inhibits PPARgamma gene expression in hepatic stellate cells in the mouse model of liver damage. Mol. Cell. En-docrinol. 323:193-200.
11. Tsukamoto H. (2005) Adipogenic phenotype of hepatic stellate cells. Alcohol Clin. Exp. Res. 29:132S-133S.
12. Rangwala SM, Lazar MA. (2000) Transcriptional control of adipogenesis. Annu. Rev. Nutr. 20:535-59.
13. Shimomura I, Shimano H, Horton JD, Goldstein JL, Brown MS. (1997) Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. J. Clin. Invest. 99:838-845.
14. She H, Xiong S, Hazra S, Tsukamoto H. (2005) Adipogenic transcriptional regulation of hepatic stellate cells. J. Biol. Chem. 280:4959-4967.
15. Potter JJ, Womack L, Mezey E, Anania FA. (1998) Transdifferentiation of rat hepatic stellate cells results in leptin expression. Biochem. Biophys. Res. Commun. 244:178-182.
16. Honda H, et al. (2002) Leptin is required for fi-brogenic responses induced by thioacetamide in the murine liver. Hepatology. 36:12-21.
17. Cassiman D, et al. (1999) Synaptophysin: a novel marker for human and rat hepatic stellate cells. Am. J. Pathol. 155:1831-1839.
18. Kammoun HL, et al. (2009) GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119:1201-1215.
19. Zhou Y, Jia X, Wang G, Wang X, Liu J. (2009) PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARgamma gene expression in primary rat hepatic stellate cells. Mol. Cell. Biochem. 325:131-139.
20. Schmittgen TD, et al. (2000) Quantitative reverse transcription-polymerase chain reaction to study mRNA decay: comparison of endpoint and realtime methods. Anal. Biochem. 285:194-204.
21. Cagen LM, et al. (2005) Insulin activates the rat sterol-regulatory-element-binding protein 1c (SREBP-1c) promoter through the combinatorial actions of SREBP, LXR, Sp-1 and NF-Y cis-acting elements. Biochem. J. 385:207-216.
22. Lee YS, et al. (2003) Twist2, a novel ADD1/ SREBP1c interacting protein, represses the tran-scriptional activity of ADD1/SREBP1c. Nucleic Acids Res. 31:7165-7174.
23. Mastrogiannaki M, et al. (2009) HIF-2alpha, but not HIF-1alpha, promotes iron absorption in mice. J. Clin. Invest. 119:1159-1166.
24. Lin J, Chen A. (2011) Curcumin diminishes the impacts of hyperglycemia on the activation of hepatic stellate cells by suppressing membrane translocation and gene expression of glucose transporter-2. Mol. Cell. Endocrinol. 333:160-167.
25. Schnabl B, et al. (2001) TAK1/JNK and p38 have opposite effects on rat hepatic stellate cells. Hepa-tology. 34:953-963.
26. Lu TT, Repa JJ, Mangelsdorf DJ. (2001) Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. J. Biol. Chem. 276:37735-37738.
27. Horton JD, Goldstein JL, Brown MS. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109:1125-1131.
28. Nogalska A, Sucajtys-Szulc E, Swierczynski J. (2005) Leptin decreases lipogenic enzyme gene expression through modification of SREBP-1c gene expression in white adipose tissue of aging rats. Metabolism. 54:1041-1047.
29. Rippe RA, Almounajed G, Brenner DA. (1995) Sp1 binding activity increases in activated Ito cells. Hepatology. 22:241-251.
30. Chen G, Liang G, Ou J, Goldstein JL, Brown MS. (2004) Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U. S. A. 101:11245-11250.
31. Repa JJ, et al. (2000) Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta. Genes. Dev. 14:2819-2830.
32. Ratziu V, et al. (2000) Liver fibrosis in overweight patients. Gastroenterology. 118:1117-1123.
33. McCullough AJ, Falck-Ytter Y. (1999) Body composition and hepatic steatosis as precursors for fibrotic liver disease. Hepatology. 29:1328-9.
34. Faggioni R, Feingold KR, Grunfeld C. (2001) Lep-tin regulation of the immune response and the immunodeficiency of malnutrition. FASEB J. 15:2565-2571.
35. Van der Poorten D, George J. (2008) Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis. Clin. Liver Dis. 12:805-824,
36. Uygun A, et al. (2000) Serum leptin levels in patients with nonalcoholic steatohepatitis. Am. J. Gastroenterol. 95:3584-3589.
37. Nakamura T, et al. (2001) Clinical implication of serial leptin measurement in subjects with type 2 diabetes mellitus. Endocr. J. 48:87-94.
38. McCullough AJ, Bugianesi E, Marchesini G, Kalhan SC. (1998) Gender-dependent alterations in serum leptin levels in alcoholic cirrhosis. Gas-troenterology. 115:947-953.
39. Polyzos SA, Kountouras J, Zavos C, Deretzi G. (2011) The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature. J. Clin. Gastroenterol. 45:50-54.